Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: Further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP)
- 1 June 2006
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 148 (6), 730-734.e1
- https://doi.org/10.1016/j.jpeds.2006.01.047
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ibuprofen prophylaxis in preterm neonatesThe Lancet, 2002
- Pulmonary hypertension after ibuprofen prophylaxis in very preterm infantsThe Lancet, 2002
- Changes in the Pathogenesis and Prevention of Chronic Lung Disease of PrematurityAmerican Journal of Perinatology, 2001
- Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infantsEarly Human Development, 2001
- Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight InfantsNew England Journal of Medicine, 2001
- Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight InfantsPediatrics, 1999
- Chronic oxygen dependency in infants born at 24–32 weeks' gestation: The role of antenatal and neonatal factorsJournal of Paediatrics and Child Health, 1997
- Changing trends in the epidemiology and pathogenesis of neonatal chronic lung diseaseThe Journal of Pediatrics, 1995
- Effects of dexamethasone and indomethacin on elastase, α1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonatesThe Journal of Pediatrics, 1988
- Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosusThe Journal of Pediatrics, 1979